Stockscreener 앱 받기
2.14
0.00%
0.00
시장 영업 전:
2.16
0.02
+0.93%
전일 마감가:
$2.14
열려 있는:
$2.15
하루 거래량:
847.71K
Relative Volume:
1.81
시가총액:
$91.99M
수익:
$51.13M
순이익/손실:
$-93.80M
주가수익비율:
-0.9596
EPS:
-2.23
순현금흐름:
$-129.10M
1주 성능:
-3.39%
1개월 성능:
+24.42%
6개월 성능:
+47.59%
1년 성능:
-46.10%
1일 변동 폭
$2.13
$2.18
1주일 범위
$2.13
$2.22
52주 변동 폭
$0.89
$2.40
Repare Therapeutics Inc Stock (RPTX) Company Profile
명칭
Repare Therapeutics Inc
전화
(857) 412-7018
주소
7171 FREDERICK BANTING, SAINT-LAURENT, QC
RPTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
2.14 | 91.99M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-06-09 | 업그레이드 | Stifel | Hold → Buy |
| 2023-02-03 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | 개시 | CapitalOne | Overweight |
| 2022-04-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-17 | 재개 | Goldman | Buy |
| 2021-09-23 | 개시 | Stifel | Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Buy |
| 2021-06-28 | 개시 | Guggenheim | Buy |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2020-10-28 | 개시 | Northland Capital | Outperform |
| 2020-07-14 | 개시 | Cowen | Outperform |
| 2020-07-14 | 개시 | Goldman | Neutral |
| 2020-07-14 | 개시 | Morgan Stanley | Overweight |
| 2020-07-14 | 개시 | Piper Sandler | Overweight |
모두보기
Repare Therapeutics Inc 주식(RPTX)의 최신 뉴스
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Repare Therapeutics (RPTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Levels Update: Will Repare Therapeutics Inc. stock gain from lower inflation2025 AllTime Highs & Expert Verified Movement Alerts - moha.gov.vn
Will Repare Therapeutics Inc. stock deliver strong dividend growth2025 Momentum Check & Risk Adjusted Swing Trade Ideas - Newser
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Repare Therapeutics Inc. (Nasdaq – RPTX), Axalta Coating Systems Ltd. (NYSE – AXTA), Blue Foundry Bancorp (Nasdaq – BLFY), Golden Entertainment, Inc ( - GlobeNewswire
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerRPTX, AXTA, WTG and SEMR - Eastern Progress
Risk Report: Why Repare Therapeutics Inc. stock is in analyst buy zone2025 Price Momentum & Daily Price Action Insights - moha.gov.vn
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights - Sahm
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Fed Watch: Is Repare Therapeutics Inc. stock a top pick in earnings seasonPortfolio Gains Report & Growth Focused Entry Reports - moha.gov.vn
BIOTECHNOLOGY VALUE FUND L P Increases Stake in Repare Therapeutics Inc - GuruFocus
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Repare shareholders vote in favor of Xeno bid - The Pharma Letter
Repare Therapeutics Inc. (RPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. - Investing News Network
Repare signs support agreements with key shareholders for Xenotherapeutics deal - marketscreener.com
Repare Therapeutics (RPTX) secures 40% shareholder support for XenoTherapeutics deal - Stock Titan
Repare Therapeutics Inc (RPTX) looking to reclaim success with recent performance - Setenews
Why hedge funds are buying Repare Therapeutics Inc. stockJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Repare Therapeutics Reports Positive Q3 2025 Results - TipRanks
Can Repare Therapeutics Inc. stock rebound after recent weaknessQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Why Repare Therapeutics Inc. stock could rally in 2025Index Update & Risk Controlled Swing Trade Alerts - newser.com
Smart tools for monitoring Repare Therapeutics Inc.’s price action2025 Momentum Check & Smart Money Movement Tracker - newser.com
TD Cowen Downgrades Repare Therapeutics (NASDAQ:RPTX) to Hold - MarketBeat
Risk adjusted return profile for Repare Therapeutics Inc. analyzedRisk Management & Technical Pattern Alert System - newser.com
Applying chart zones and confluence areas to Repare Therapeutics Inc.July 2025 Snapshot & Daily Entry Point Alerts - newser.com
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Candlestick signals on Repare Therapeutics Inc. stock todayJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Stock Traders Purchase High Volume of Call Options on Repare Therapeutics (NASDAQ:RPTX) - MarketBeat
Repare Therapeutics Target of Unusually Large Options Trading (NASDAQ:RPTX) - Defense World
Repare Therapeutics Announces Acquisition by XenoTherapeutics - MSN
Real time scanner hits for Repare Therapeutics Inc. explainedJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An - GlobeNewswire
Repare Therapeutics Gains Attention Amid Acquisition Buzz - StocksToTrade
Cambridge-Montreal biotech Repare Therapeutics to be acquired by XenoTherapeutics - The Business Journals
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025 - ts2.tech
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - inkl
Repare Therapeutics Unveils Phase 1 LIONS Trial Data - MSN
[8-K] Repare Therapeutics Inc. Reports Material Event | RPTX SEC FilingForm 8-K - Stock Titan
Repare Therapeutics (RPTX) on Acquisition Path: Explained - timothysykes.com
Repare Therapeutics Inc (RPTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):